Vor Biopharma Inc
NASDAQ:VOR
Fundamental Analysis

Revenue & Expenses Breakdown
Vor Biopharma Inc
Balance Sheet Decomposition
Vor Biopharma Inc
Current Assets | 64.8m |
Cash & Short-Term Investments | 60m |
Other Current Assets | 4.8m |
Non-Current Assets | 44.5m |
PP&E | 39.7m |
Other Non-Current Assets | 4.8m |
Free Cash Flow Analysis
Vor Biopharma Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Vor Biopharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-122.2m
USD
|
Operating Income
|
-122.2m
USD
|
Other Expenses
|
3.6m
USD
|
Net Income
|
-118.6m
USD
|
VOR Profitability Score
Profitability Due Diligence
Vor Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Vor Biopharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
VOR Solvency Score
Solvency Due Diligence
Vor Biopharma Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Score
Vor Biopharma Inc's solvency score is 57/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VOR Price Targets Summary
Vor Biopharma Inc
Dividends
Current shareholder yield for VOR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?